Burkitt's Lymphoma at the center of Catholic investigation

According to the Catholic News Agency, a 31 year old Italian woman was cured of Burkitt's lymphoma after her husband prayed vigorously for Papal intercession in 2005.

In an odd twist, however, the husband reported that Pope John Paul II appeared to him in a dream, telling him he could do nothing for his wife. Instead, he should pray to another priest, whom the husband did not recognize. Some time later, the man came across a picture of Pope Pius XII and recognized him as the priest whom John Paul II had referred to.

The husband "wasted no time bombarding Pius XII with prayers for his wife's healing" and after a single treatment, the woman was pronounced free of cancer. Church authorities are investigating the entire incident as a potential miracle—the kind that could, if cleared by Vatican officials by way of the Congregation for the Causes of Saints, help pave the way for Pius XII's sainthood.

The Venerable Pope Pius XII, born Eugenio Pacelli, served as the 258th Roman Pontiff from 1939 until his death in 1958. His pontificate has often been criticized for not doing enough to protest the holocaust during World War II.

By Ross Bonander

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap